| Previous Close | 23.37 |
| Open | 22.63 |
| Bid | 18.41 x 800 |
| Ask | 18.48 x 1200 |
| Day's Range | 18.10 - 22.80 |
| 52 Week Range | 12.88 - 59.49 |
| Volume | 1,526,969 |
| Avg. Volume | 511,396 |
| Market Cap | 882.787M |
| Beta (5Y Monthly) | 2.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Why Constellation Pharmaceuticals (CNST) Might Surprise This Earnings Season?
Constellation Pharmaceuticals (CNST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
What Type Of Shareholders Make Up Constellation Pharmaceuticals, Inc.'s (NASDAQ:CNST) Share Registry?
Every investor in Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) should be aware of the most powerful shareholder...
- Zacks
Constellation Pharmaceuticals, Inc. (CNST) Upgraded to Buy: What Does It Mean for the Stock?
Constellation Pharmaceuticals, Inc. (CNST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
© 2020 Verizon Media. All rights reserved.
